logo
EN 简体 繁体
EN 简体 繁体
  • About Us
    • Company Profile
    • Milestones
    • Our Team
    • Investors
    • Partnership & Recognition
    • Contact Us
  • CANbridge in Rare Disease Community
  • Pipeline & Products
    • Pipeline
      • Rare Diseases
      • Gene Therapy
    • Approved Products
      • Livmarli®
      • Hunterase®
  • Investors
    • Information Disclosure
      • Listing Documents
      • Financial Reports
      • Announcements & Circulars
    • Corporate Governance
    • Stock Information
    • Presentations & Webcasts
    • Analyst Coverage
    • Financial Calendar
    • Email Alert and IR Contact
    • Electronic Dissemination of Corporate Communications
  • Media & News
    • Media Reports
    • Press Release
  • Corporate Culture & Career
    • Corporate Culture
    • Open Positions
Financial Reports
2024
2024 Interim Report
Interim Results Announcement for the Six Months Ended 30 June,2024
2023
2023 Annual Report
2023 ESG Report
Annual Results Announcement for The Year Ended December 31, 2023
2023 Interim Report
2022
2022 Annual Report
2022 ESG Report
Annual Results Announcement for The Year Ended December 31, 2022
2022 Interim Report
Interim Results Announcement for the Six Months Ended 30 June,2022
  • 1
  • 2
  • About Us
    • Company Profile
    • Milestones
    • Our Team
    • Investors
    • Partnership & Recognition
    • Contact Us
  • CANbridge in Rare Disease Community
  • Pipeline & Products
    • Pipeline
      • Rare Diseases
      • Gene Therapy
    • Approved Products
      • Livmarli®
      • Hunterase®
  • Investors
    • Information Disclosure
      • Listing Documents
      • Financial Reports
      • Announcements & Circulars
    • Corporate Governance
    • Stock Information
    • Presentations & Webcasts
    • Analyst Coverage
    • Financial Calendar
    • Email Alert and IR Contact
    • Electronic Dissemination of Corporate Communications
  • Media & News
    • Media Reports
    • Press Release
  • Corporate Culture & Career
    • Corporate Culture
    • Open Positions
Privacy Policy  Copyright ©:CANbridge Life Sciences Ltd.   ICP:12036158-1  京公网安备11010502044059号 互联网药品信息服务资格证编号(京)-非经营性-2021-0065  Developed by Euroland IR